ARTICLE | Clinical News
Herzyme: Began Clinical Testing
March 5, 2001 8:00 AM UTC
Ribozyme Pharmaceuticals Inc. (RZYM), Boulder, Colo. Product: Herzyme Business: Cancer Therapeutic category: Cell proliferation Target: Human epidermal growth factor 2 ( HER2) Description: Ribozyme in...